Welcome to Medications.com

Idera Signs $421M Deal For TLR9 Cancer Agonists - BioWorld Online

Just one TLR drug has made it to market - Graceway Pharmaceuticals LLC markets the TLR7 drug Aldara (imiquimod) for superficial basal cell carcinomas, ...

http://www.bioworld.com/servlet/c... | Posted: Thu Dec 20 00:03:57 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea